Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] [Phase 3]
Phase 3 trial comparing atezolizumab with platinum-based chemotherapy in stage IV NSCLC shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC [Phase 3]
Phase 3 trial evaluating sintilimab for advanced/metastatic non-squamous non-small cell lung cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial evaluating pembrolizumab in combination with nab-paclitaxel in non-small cell lung cancer has completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update on chemoradiotherapy for Stage III non-small cell lung cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab with chemoradiotherapy in unresectable locally advanced non-small cell lung cancer has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer [Phase 2, Phase 3]
A clinical trial comparing HX008 plus chemotherapy to pembrolizumab plus chemotherapy as first-line treatment for advanced or metastatic non…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma [Phase 2]
Phase 2 trial evaluating a mid-position strategy in radiotherapy for locally advanced, non-metastatic non-small cell lung cancer; study comp…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas) [Phase 3]
Phase 3 trial of SBRT in newly diagnosed stage IV EGFR-mutated non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating trametinib in combination with docetaxel for KRAS-mutant non-small cell lung cancer; results have been posted and t…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Phase 1/2 Study of SC-43 in Combination With Cisplatin [Phase 1, Phase 2]
Phase 1/2 study investigating SC-43 in combination with cisplatin in advanced cancers including non-small cell lung cancer and biliary tract…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC [Phase 3]
Phase 3 trial comparing MYL-1402O with Avastin in stage IV non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions [Phase 2]
Phase 2 trial evaluating pyrotinib plus thalidomide in advanced non-small-cell lung cancer with HER2 exon 20 insertions.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer [NA]
Phase II study on image-guided stereotactic ablative radiotherapy for non-small cell lung cancer; trial terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Pegilodecakin (LY3500518) + pembrolizumab versus pembrolizumab alone as first-line therapy in metastatic non-small …
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating split-course chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating romidepsin plus erlotinib in stage III/IV non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment [Phase 2]
A Phase 2 trial evaluating pyrotinib with pemetrexed and carboplatin as first-line therapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC [Phase 2]
Phase 2 trial evaluating nivolumab combined with radiotherapy in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) [Phase 2]
Phase 2 trial evaluating stereotactic radiosurgery or local ablation followed by erlotinib in non-small cell lung cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC [Phase 2]
Phase 2 trial evaluating almonertinib with concurrent radiotherapy in locally advanced EGFR-mutant non-small cell lung cancer (Stage III NSC…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating first-line anti-PD-1/PD-L1 monoclonal antibody plus chemotherapy with bronchoscopy-assisted interventional therap…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Navelbine And Radiotherapy in Locally Advanced Lung Cancer [Phase 2]
Phase 2 trial update for Navelbine with radiotherapy in locally advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Central Nervous System(CNS) Efficacy of Dacomitinib [Phase 2]
Phase 2 trial update assessing CNS efficacy of dacomitinib in non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). [Phase 2]
Phase 2 trial evaluating R1507 plus Erlotinib in non-squamous non-small cell lung cancer; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. [Phase 2]
Phase 2 trial evaluating LDK378 (brigatinib) in ALK-positive non-small cell lung cancer patients previously treated with alectinib has compl…